Reaction Details |
| Report a problem with these data |
Target | Alpha-2C adrenergic receptor |
---|
Ligand | BDBM50257088 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEBML_1689226 |
---|
Ki | 575±n/a nM |
---|
Citation | He, S; Li, K; Lin, B; Hu, Z; Xiao, J; Hu, X; Wang, AQ; Xu, X; Ferrer, M; Southall, N; Zheng, W; Aubé, J; Schoenen, FJ; Marugan, JJ; Liang, TJ; Frankowski, KJ Development of an Aryloxazole Class of Hepatitis C Virus Inhibitors Targeting the Entry Stage of the Viral Replication Cycle. J Med Chem60:6364-6383 (2017) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Alpha-2C adrenergic receptor |
---|
Name: | Alpha-2C adrenergic receptor |
Synonyms: | ADA2C_HUMAN | ADRA2C | ADRA2L2 | ADRA2RL2 | Adrenergic alpha2C | Adrenergic receptor | Adrenergic receptor alpha | Adrenergic, alpha-2C-, receptor | Alpha-2 adrenergic receptor subtype C4 | Alpha-2C adrenoceptor | Alpha-2C adrenoreceptor | adrenergic, alpha-2C-, receptor [Homo sapiens] |
Type: | Enzyme |
Mol. Mass.: | 49552.32 |
Organism: | Homo sapiens (Human) |
Description: | P18825 |
Residue: | 462 |
Sequence: | MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGF
LIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFG
QVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISA
VISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLR
TRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGA
LRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRR
RRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFK
FFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ
|
|
|
BDBM50257088 |
---|
n/a |
---|
Name | BDBM50257088 |
Synonyms: | CHEMBL4066784 |
Type | Small organic molecule |
Emp. Form. | C28H41ClN4O2 |
Mol. Mass. | 501.104 |
SMILES | C[C@H]1C[C@@H](C)CN(CCCNC(=O)C2CCN(Cc3nc(oc3C)-c3c(C)cccc3Cl)CC2)C1 |r| |
Structure |
|